Harmony Biosciences CEO Jeffrey Dayno to exit at year end; shares fall
Investor's Business Daily reported that Harmony Biosciences announced the transition of current CEO Jeffrey Dayno at the end of the year. The report states that the company's stock took a tumble Monday following the announcement.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Harmony Biosciences announced the transition of current CEO Jeffrey Dayno at the end of the year.
“announced the transition of current CEO Jeffrey Dayno at the end of the year”
Investor's Business Daily -
Harmony Biosciences stock fell on Monday after the CEO transition announcement.
“Harmony Biosciences stock took a tumble Monday”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-12 14:20 UTC. Labels are computed from the sources, not by the model.